Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient

Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal form of diffuse interstitial lung disease. Management of IPF requires an orderly approach, with regular evaluations and implementation of both pharmacological and nonpharmacological treatments. Pulmonary rehabilitation can relieve...

Full description

Bibliographic Details
Main Author:	J.J. Egan
Format:	Article
Language:	English
Published:	European Respiratory Society 2011-06-01
Series:	European Respiratory Review
Subjects:	Idiopathic pulmonary fibrosis lung allocation score lung transplantation oxygen therapy palliative care pulmonary rehabilitation
Online Access:	http://err.ersjournals.com/content/20/120/114.full.pdf+html

Similar Items

Lung transplantation for idiopathic pulmonary fibrosis: A narrative review
by: Nazia Mehfooz, et al.
Published: (2021-01-01)

Lung Transplantation in Idiopathic Pulmonary Fibrosis
by: Rosalía Laporta Hernandez, et al.
Published: (2018-08-01)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
by: Paloma Millan-Billi, et al.
Published: (2018-07-01)

Idiopathic pulmonary fibrosis with complication of severe respiratory failure, right heart failure, and steroid induced diabetes – qualification for lung transplantation as a matter of urgency
by: Beata P. Kraśnicka-Sokół, et al.
Published: (2016-09-01)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
by: Elisabetta Balestro, et al.
Published: (2019-10-01)

A case of lung adenocarcinoma with idiopathic pulmonary fibrosis
by: Arnab Saha, et al.
Published: (2014-01-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)

The efficacy of pulmonary rehabilitation in improving the clinical status in idiopathic pulmonary fibrosis
by: MOTOC Nicoleta Stefania, et al.
Published: (2020-02-01)

Erythropoietin: role in idiopathic pulmonary fibrosis revisited
by: Contributors A.O Abdel-Aziz, et al.
Published: (2020-01-01)

Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample
by: Adam W. Gaffney, et al.
Published: (2018-08-01)

Differential diagnosis of idiopathic pulmonary fibrosis
by: E. I. Shmelev, et al.
Published: (2020-03-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Retrospective cohort study of patients qualified for lung transplantation due to idiopathic pulmonary fibrosis – single-centre experience
by: Marek Ochman, et al.
Published: (2019-01-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01)

Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data
by: Joo Heung Yoon, et al.
Published: (2018-10-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
by: Lucile Sesé, et al.
Published: (2021-08-01)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
by: Shaney L. Barratt, et al.
Published: (2018-08-01)

Research Progress in the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Cancer
by: Chunhui LIU, et al.
Published: (2020-08-01)

Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
by: Hasancan Bilgili, et al.
Published: (2019-08-01)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
by: Amarpreet Kaur, et al.
Published: (2017-09-01)

A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis
by: Alan Betensley, et al.
Published: (2016-12-01)

Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype
by: Emily Fraser, et al.
Published: (2021-03-01)

Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
by: P. Heukels, et al.
Published: (2018-05-01)

Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
by: Cha Seung-Ick, et al.
Published: (2012-11-01)

Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends
by: Giacomo Sgalla, et al.
Published: (2020-09-01)

Effect of nintedanib on non‐small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review
by: Toshihiro Shiratori, et al.
Published: (2020-06-01)

Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
by: Nada Taha, et al.
Published: (2020-05-01)

Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Nizar Rifaat, et al.
Published: (2014-10-01)

Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis
by: Josep Mercader-Barceló, et al.
Published: (2020-08-01)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
by: Shengnan Yang, et al.
Published: (2021-03-01)

Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis
by: Sabah Ahmed, et al.
Published: (2016-01-01)

Idiopathic pulmonary fibrosis: pathogenesis and management
by: Giacomo Sgalla, et al.
Published: (2018-02-01)

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
by: Andreas Guenther, et al.
Published: (2018-07-01)

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses
by: Alice Guyard, et al.
Published: (2017-06-01)

Idiopathic pulmonary fibrosis: The current state of the problem
by: E I Shmelev
Published: (2016-12-01)

Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function
by: Xiyue Zhang, et al.
Published: (2021-04-01)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
by: Ulrich Costabel, et al.
Published: (2019-03-01)

Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
by: Elisa Baratella, et al.
Published: (2021-04-01)

The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review
by: Richard H. Zou, et al.
Published: (2020-01-01)